Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. - Wikidata - wikimedia - TriplyDB

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

http://www.wikidata.org/entity/Q37298463

about

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and Uric acid and chronic kidney disease: which is chasing which?Effect of redox modulating NRF2 activators on chronic kidney disease Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Hyperuricemia and overexcretion of uric acid increase the risk of simple renal cysts in type 2 diabetes.Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats.Comorbidities in patients with crystal diseases and hyperuricemia.Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway.Diabetic nephropathy - complications and treatment.Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy.Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice.Uric acid as a mediator of diabetic nephropathy.Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.Serum Uric Acid and Risk of CKD in Type 2 Diabetes Uric acid as a target of therapy in CKD.Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy Fructose and uric acid in diabetic nephropathy Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-κB Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).Oxidative stress in diabetic nephropathy.CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy.Low protein diet inhibits uric acid synthesis and attenuates renal damage in streptozotocin-induced diabetic rats.Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes.Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.Allopurinol, uric acid, and oxidative stress in cardiorenal disease.The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review.Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?Time to target uric acid to retard CKD progression.Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation.

P2860

Q24235651-02C39276-9A0F-41FE-B8A9-A4D1F29094CC Q26740021-C9C6C19A-871B-4817-AC11-05C259367567 Q26824554-E02AD9F1-DE86-40A3-8515-699637819A21 Q26827726-D13CBB86-F6A9-4FDA-8876-82A8382C8DA4 Q28354735-DD8FF73B-892A-454F-9024-BD003D69F5C6 Q28480520-E5B5D4EB-CA2E-460C-B086-19FFA3547A65 Q33634704-F8F65D80-D1C7-4FB5-B322-FC4F91D60BCD Q33812573-CAB77676-E742-4184-8032-A6369D7A80BC Q33988764-5F6E3258-DE58-4438-AB86-5DF8E7846240 Q34128253-364D1F42-765B-42F1-BA58-1DBA28B96527 Q34157725-A665B711-27E3-46B0-9257-DB9AC7C6AC08 Q34305376-A51A0008-7980-4B6A-813F-1E3C13D7FFCC Q34326473-5739C37C-2CED-4718-8824-2702B3101229 Q34387952-F0422B1C-B959-4A1F-B83E-176BC60FA7CA Q34427632-5A72B521-2053-402D-8D9C-29E8FB0222F7 Q34718837-584C16BD-D16E-486E-87EF-E8F4396D3FF0 Q34724943-FA53A134-F006-45A6-8AFA-C8C8E5A4EE31 Q34737229-88F2F132-22FE-47A3-80C2-25401611BD32 Q35036205-3F74B0FF-3DE9-49A9-BAEE-4D4191B61265 Q35048212-8E00C68E-D852-4DE0-BFF1-19A02ACEDB5C Q35393446-5C73D0D4-6BA7-4694-B161-49FA661C47E5 Q36100197-1E69E334-33AD-4C97-BF5B-F8BD1AFABDF5 Q36166872-CDFE5003-F0ED-43A3-8A0E-FC8AA49E9046 Q36250295-555FFED8-229F-43BA-833D-D0268A76AC3C Q36476464-88131EB8-1FE0-44A7-B0B6-1BD505102CF6 Q36550886-1452647D-850D-45F2-AD16-D6E0B4794003 Q36629471-D8B07AD8-0002-433B-9736-E52C5BF31752 Q36782938-7472599A-B46B-4622-851B-1A0B48372143 Q36870285-A32121F1-9546-418D-9F59-D77D30CC6A57 Q36948557-8FB60C93-23C4-4FAC-8656-343335359A51 Q37003803-301B0125-8E1E-43BE-A5C3-4EE3B0DD4E09 Q37604704-E0250E3C-3163-4BD9-A35E-D6C4CB1D908B Q37686722-B2092B8D-9AB2-4317-A5AD-EE0118B72943 Q37707005-C11DA35E-60D0-4328-8A83-67FD4C537253 Q37780781-88D770BB-7147-4F8F-872D-669F6D272E50 Q37872639-629CFC79-8FC7-469A-83FF-BB7B0763652B Q37982966-CA0C0E90-141A-4958-B659-4ACCBCCE62ED Q38553908-93F1B413-D321-45DA-9C3F-702777CA0416 Q38848997-0E62B221-4DFC-4F03-A07A-1F4630BD33D3 Q39244162-4CC8B2FF-6042-42DF-91A3-1B8B35074D86

P2860

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

http://www.wikidata.org/entity/Q37298463

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@en

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@nl

type

label

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@en

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@nl

prefLabel

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@en

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@nl

P1433

Q37298463-1AB4F1A1-272F-4EA3-BA6E-E94734261E7C

P1476

Q37298463-AD013C3A-38FC-4AE2-8B0F-E1EE338F6D8F

P2093

Q37298463-027914A9-662C-44E5-8316-40D129C4F179

Q37298463-4711234C-4046-4551-BEF8-41020BBFB258

Q37298463-47F2B556-BC4F-45FE-BDDE-E034BF3DA209

Q37298463-5A8DFBF1-F623-4D04-8C0A-A4792D24E657

Q37298463-7624D053-898D-45FD-98D6-5ACE9E56F6C2

Q37298463-8F9FBC7E-67AB-4FC6-BAC0-0C10B4579794

Q37298463-B6BD903B-7A25-4113-9D9E-BE75E7F9F986

Q37298463-C350ECB3-A382-4EDC-9FD8-A7808E936C73

Q37298463-E78CAEBA-FB50-4EC3-B5B5-D582FC8E5628

P2860

Q37298463-09396A40-DD76-418C-B9E3-053D72964A3E

Q37298463-15C7A3AB-46F4-48B0-8379-0E66DC230DDC

Q37298463-18BD7ABC-7F92-4176-930A-00AE712ADE9A

Q37298463-1AFEB67D-864F-4203-8239-F39713176D1E

Q37298463-1E5946BE-F301-40E3-9F19-A10B25146AB9

Q37298463-24DE6ABA-6651-4DBA-B642-F72426C1FCE1

Q37298463-2F0B148A-37E7-4330-84ED-609CE6D9C251

Q37298463-36269C26-380E-4765-BD93-DE250DC8E41D

Q37298463-3D2F6C3C-526E-45E9-B4B3-7584EBAAD178

Q37298463-477B41C5-C56F-4E88-9F63-9851A6FA6A92

P304

Q37298463-6E55F5FD-97D0-40E0-A64B-6704786AA724

P31

Q37298463-FA7AD86A-2E18-4B6A-AA29-D060F1D2992F

P356

Q37298463-F195D6D5-7FD4-4876-B105-3F3E75B8AA3D

P433

Q37298463-CF47EBBE-717E-4C12-8554-B6E6C47287E5

P478

Q37298463-DFE7977F-AFC0-4955-ABA4-0CFBF38AF267

P577

Q37298463-185141AF-0246-43C9-9885-A2E5CB646AFC

P5875

Q37298463-8D9C9B62-6474-4B50-BDB4-1D4B6BCBBE89

P698

Q37298463-99A10916-C5FB-4DFA-B698-42EE848A1DD0

P932

Q37298463-4AFD301A-CA8F-4952-A89D-2F9996AF7484

P356

AJPRENAL.00092.2009

P1433

American Journal of Physiology - Renal Physiology

P1476

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

@en

P2093

Carlos Roncal

http://www.w3.org/2001/XMLSchema#string

Laura Gabriela Sanchez-Lozada

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Marcelo Heinig

http://www.w3.org/2001/XMLSchema#string

Richard J Johnson

http://www.w3.org/2001/XMLSchema#string

Takahiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

Takahiro Nakayama

http://www.w3.org/2001/XMLSchema#string

Tomoki Kosugi

http://www.w3.org/2001/XMLSchema#string

Yukio Yuzawa

http://www.w3.org/2001/XMLSchema#string

P2860

Leukocyte recruitment and vascular injury in diabetic nephropathy.

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

A causal role for uric acid in fructose-induced metabolic syndrome.

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.

Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Hyperuricemia in childhood primary hypertension.

Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

P304

F481-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00092.2009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24442340

http://www.w3.org/2001/XMLSchema#string

P698

19458127

http://www.w3.org/2001/XMLSchema#string

P932

2724243

http://www.w3.org/2001/XMLSchema#string